Atlas Trials

Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer

Clinical trial NCT01890213 · COMPLETED

Trial details

NCT number
NCT01890213
Sponsor
Duke University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Stage III Colon Cancer
Start date
2013-11-01
Primary completion
2017-06-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.